Skip to content

CAXTON CORP

Follow

13F filer, CIK 1388551, Princeton, NJ

CAXTON CORP reported $2,783,915 across 13 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 96.36% of the portfolio.

Accepted , ingested 13F-HR 0000919574-26-007854

Changes against Q2 2026 are not shown: its report omitted holdings under a confidential treatment request (10 positions on file), so every position would read as new.

The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.

Period
2026-09-30
Reported value
$2.78M
Holdings
13
Top 10 weight
96.36%
New
Sold out

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000919574-26-007854, largest first. % of portfolio is the value over $2,783,915, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPCXSPACE EXPLORATION TECHN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,606 shares; 2026Q3: 3,699 shares 3,699$558K20.04%The filing omitted confidential holdings, a later amendment may add them.Timeline
NFEGPNEW FORTRESS ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,214 shares 1,214$486K17.44%The filing omitted confidential holdings, a later amendment may add them.Timeline
BRK-BBERKSHIRE HATHAWAY INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,133 shares; 2025Q1: 467 shares; 2025Q2: 632 shares; 2025Q3: 651 shares; 2025Q4: 710 shares; 2026Q1: 727 shares; 2026Q2: 754 shares; 2026Q3: 839 shares 839$418K15%The filing omitted confidential holdings, a later amendment may add them.Timeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 829 shares 829$294K10.57%The filing omitted confidential holdings, a later amendment may add them.Timeline
VOOVANGUARD INDEX FDSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 339 shares; 2026Q3: 378 shares 378$265K9.51%The filing omitted confidential holdings, a later amendment may add them.Timeline
GOOGLALPHABET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 691 shares; 2026Q3: 769 shares 769$265K9.5%The filing omitted confidential holdings, a later amendment may add them.Timeline
BXBLACKSTONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,597 shares; 2026Q3: 1,780 shares 1,780$200K7.17%The filing omitted confidential holdings, a later amendment may add them.Timeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,981 shares; 2025Q1: 22,981 shares; 2025Q2: 22,981 shares; 2025Q3: 22,981 shares; 2025Q4: 18,773 shares; 2026Q1: 18,773 shares; 2026Q2: 12,347 shares; 2026Q3: 12,347 shares 12,347$84K3.02%The filing omitted confidential holdings, a later amendment may add them.Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 17,851 shares; 2025Q1: 17,851 shares; 2025Q2: 17,332 shares; 2025Q3: 17,332 shares; 2025Q4: 13,943 shares; 2026Q1: 13,943 shares; 2026Q2: 16,962 shares; 2026Q3: 16,962 shares 16,962$57.3K2.06%The filing omitted confidential holdings, a later amendment may add them.Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,393 shares; 2025Q1: 16,393 shares; 2025Q2: 16,393 shares; 2025Q3: 16,393 shares; 2025Q4: 28,453 shares; 2026Q1: 28,453 shares; 2026Q2: 28,453 shares; 2026Q3: 27,775 shares 27,775$57.1K2.05%The filing omitted confidential holdings, a later amendment may add them.Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,557 shares; 2026Q1: 15,557 shares; 2026Q2: 15,557 shares; 2026Q3: 13,534 shares 13,534$39.2K1.41%The filing omitted confidential holdings, a later amendment may add them.Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,935 shares; 2025Q4: 10,527 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,372 shares 10,372$32.9K1.18%The filing omitted confidential holdings, a later amendment may add them.Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,946 shares; 2026Q2: 20,946 shares; 2026Q3: 20,946 shares 20,946$29.1K1.05%The filing omitted confidential holdings, a later amendment may add them.Timeline

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-26-007854 base2026-11-16